A mucus hypersecretory phenotype is a dominant characteristic of chronic ai
rways diseases such as chronic bronchitis and asthma. This phenotype develo
ps following chronic exposure of the respiratory tract to particulate matte
r, allergens, irritants and/or pathogens. The associated increase in the mu
cus-producing potential of the respiratory epithelium represents an innate
host response that can be modulated by elements of the adaptive host respon
se. Although elevation of mucus production is designed to protect the airwa
ys, increasing evidence suggests that in excess it can be detrimental to he
alth. Considerable progress has been made over the past five years in under
standing the mechanisms involved in the development and regulation of the h
ypersecretory phenotype. This progress has set the stage for the developmen
t of successful dedicated mucomodulatory strategies to counter the negative
impact of excess mucus production in respiratory disease.